A retrospective cohort study of isoniazid-resistant tuberculosis treatment outcomes and isoniazid resistance-associated mutations in eastern China from 2013 to 2018.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of global antimicrobial resistance"
DOI: 10.1016/j.jgar.2020.07.012
Abstract: BACKGROUND The current situation of rifampicin-susceptible, isoniazid-resistant tuberculosis (Hr-TB) and associated genetic factors were not clear in China. METHODS A retrospective cohort study was conducted from 2013 to 2018 in Jiangsu province. The phenotypic Hr-TB… read more here.
Keywords: resistant tuberculosis; retrospective cohort; isoniazid resistant; unfavorable outcomes ... See more keywords
S152 Investigating the role of fluoroquinolones in the treatment of isoniazid resistant tuberculosis: implications for the 2018 WHO guidance
Sign Up to like & getrecommendations! Published in 2018 at "Thorax"
DOI: 10.1136/thorax-2018-212555.158
Abstract: 2018 World Health Organization (WHO) guidelines for isoniazid resistant (INH-R) tuberculosis recommend a treatment regimen of four drugs continuously for six months- rifampicin, pyrazinamide, ethambutol, and levofloxacin; with or without isoniazid ([H]RZE-Lfx)- once drug sensitivity… read more here.
Keywords: fluoroquinolones treatment; regimen specific; treatment; isoniazid resistant ... See more keywords